METHENAMINE HIPPURATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for methenamine hippurate and what is the scope of patent protection?
Methenamine hippurate
is the generic ingredient in three branded drugs marketed by Ss Pharma, Aurobindo Pharma Ltd, Impax Labs Inc, Jubilant Cadista, Micro Labs, Novast Labs, and Alvogen, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for methenamine hippurate. Nine suppliers are listed for this compound.
Summary for METHENAMINE HIPPURATE
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 7 |
| NDAs: | 7 |
| Drug Master File Entries: | 10 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| Clinical Trials: | 6 |
| Patent Applications: | 3,013 |
| Drug Prices: | Drug price trends for METHENAMINE HIPPURATE |
| What excipients (inactive ingredients) are in METHENAMINE HIPPURATE? | METHENAMINE HIPPURATE excipients list |
| DailyMed Link: | METHENAMINE HIPPURATE at DailyMed |
Recent Clinical Trials for METHENAMINE HIPPURATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Texas Southwestern Medical Center | Phase 4 |
| Washington University School of Medicine | Phase 4 |
| UMC Utrecht | Phase 4 |
Medical Subject Heading (MeSH) Categories for METHENAMINE HIPPURATE
Anatomical Therapeutic Chemical (ATC) Classes for METHENAMINE HIPPURATE
US Patents and Regulatory Information for METHENAMINE HIPPURATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jubilant Cadista | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 217675-001 | Dec 1, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novast Labs | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 210068-001 | Nov 27, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo Pharma Ltd | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 205661-001 | Jul 5, 2016 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Impax Labs Inc | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 076411-001 | Jun 20, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
